See every side of every news story
Published loading...Updated

U.S. FDA authorizes Pfizer's COVID booster shot for young children

Summary by Ground News
Pfizer requested this EUA at the end of April. Company data showed that a third vaccine dose raised Omicron-fighting antibodies by 36 times. 4,500 children ages 5 through 11 participated in the Pfizer/BioNTech Covid-19 vaccine trial.

273 Articles

All
Left
63
Center
140
Right
26
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 61% of the sources are Center
61% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Stars and Stripes broke the news in Washington, United States on Monday, May 16, 2022.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.